Trials for neurodegenerative diseases: time to innovate. (2021)
Attributed to:
Cellular and molecular insights into neurodegeneration mediated by the C9orf72 gene mutation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1474-4422(21)00388-4
PubMed Identifier: 34800413
Publication URI: http://europepmc.org/abstract/MED/34800413
Type: Journal Article/Review
Volume: 20
Parent Publication: The Lancet. Neurology
Issue: 12
ISSN: 1474-4422